Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach

This publication has 52 references indexed in Scilit:

• Impact of different inhibitor reactivities with commercial factor VIII concentrates on thrombin generation
  Haemophilia, 2006
• Novel therapies for immune tolerance in haemophilia A
  Haemophilia, 2006
• Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors
  British Journal of Haematology, 2006
• Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors
  Haemophilia, 2006
• The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation
  British Journal of Haematology, 2006
• Consensus recommendations for use of central venous access devices in haemophilia
  Haemophilia, 2004
• Thrombotic complications in patients with hereditary bleeding disorders
  Thrombosis and Haemostasis, 2004
• Successful treatment of high titer inhibitors in mild hemophilia A with avoidance of factor VIII and immunosuppressive therapy
  American Journal of Hematology, 2001
• Summary of clinical experience with recombinant factor VIII products — Kogenate
  Annals of Hematology, 1994
• Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIII
  New England Journal of Medicine, 1988